IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,033,892 | +27.2% | 177,114 | +0.2% | 0.00% | +33.3% |
| Q2 2023 | $6,316,437 | 0.0% | 176,733 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,316,437 | -4.9% | 176,733 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $6,639,814 | -99.9% | 175,796 | -37.1% | 0.00% | -57.1% |
| Q3 2022 | $12,367,770,000 | +62.3% | 279,624 | +35.9% | 0.01% | +75.0% |
| Q2 2022 | $7,618,308,000 | -0.6% | 205,789 | -0.5% | 0.00% | +33.3% |
| Q1 2022 | $7,663,798,000 | +37.1% | 206,906 | +12.6% | 0.00% | +50.0% |
| Q4 2021 | $5,591,574,000 | -7.7% | 183,752 | +1.7% | 0.00% | -33.3% |
| Q3 2021 | $6,059,505,000 | -13.9% | 180,665 | +2.5% | 0.00% | 0.0% |
| Q2 2021 | $7,034,243,000 | -61.3% | 176,341 | -56.4% | 0.00% | -62.5% |
| Q1 2021 | $18,187,398,000 | -21.4% | 404,524 | -1.2% | 0.01% | -27.3% |
| Q4 2020 | $23,153,753,000 | +39.9% | 409,511 | +17.4% | 0.01% | +22.2% |
| Q3 2020 | $16,555,258,000 | -17.1% | 348,899 | +3.0% | 0.01% | -25.0% |
| Q2 2020 | $19,966,214,000 | +17.1% | 338,640 | -6.1% | 0.01% | 0.0% |
| Q1 2020 | $17,055,409,000 | -20.1% | 360,732 | +2.0% | 0.01% | -7.7% |
| Q4 2019 | $21,357,713,000 | +5.7% | 353,546 | +4.8% | 0.01% | -7.1% |
| Q3 2019 | $20,203,689,000 | -6.4% | 337,234 | +0.4% | 0.01% | -6.7% |
| Q2 2019 | $21,596,457,000 | +107.2% | 336,027 | +161.6% | 0.02% | +87.5% |
| Q1 2019 | $10,425,231,000 | +71.2% | 128,437 | +14.0% | 0.01% | +60.0% |
| Q4 2018 | $6,088,347,000 | +9.7% | 112,622 | +4.7% | 0.01% | +25.0% |
| Q3 2018 | $5,547,738,000 | +25.3% | 107,556 | +1.2% | 0.00% | +33.3% |
| Q2 2018 | $4,429,188,000 | -64.3% | 106,292 | -62.2% | 0.00% | -70.0% |
| Q1 2018 | $12,389,698,000 | -14.0% | 281,073 | -1.9% | 0.01% | -16.7% |
| Q4 2017 | $14,411,805,000 | +5.2% | 286,517 | +6.0% | 0.01% | 0.0% |
| Q3 2017 | $13,698,836,000 | +2.1% | 270,194 | +2.4% | 0.01% | -7.7% |
| Q2 2017 | $13,421,389,000 | +4.9% | 263,837 | -17.1% | 0.01% | 0.0% |
| Q1 2017 | $12,798,073,000 | +86914.4% | 318,360 | +3.5% | 0.01% | -18.8% |
| Q4 2016 | $14,708,000 | +22.4% | 307,483 | -6.2% | 0.02% | +23.1% |
| Q3 2016 | $12,013,000 | +9.6% | 327,871 | -30.4% | 0.01% | +8.3% |
| Q2 2016 | $10,965,000 | -72.0% | 470,805 | -51.3% | 0.01% | -73.3% |
| Q1 2016 | $39,172,000 | -32.1% | 967,206 | +3.8% | 0.04% | -31.8% |
| Q4 2015 | $57,720,000 | – | 931,996 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |